category,datetime,headline,id,image,related,source,summary,url
company,1768855440,"Down 55%, Should You Buy the Dip on Pfizer?",138180931,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?",https://finnhub.io/api/news?id=90461fe2b10ef9c117a39ff656e5a36792ceef896cca2c913a981ad8f3b24764
company,1768854180,"Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All",138190298,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.",https://finnhub.io/api/news?id=57367d017880e4664e991c3a9622229984c34e45963c36c3e5766ccee9fb26e8
company,1768839240,The Magnificent 7 is Over: What Stocks Will Replace It?,138178948,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,Amazon and Tesla have underperformed for 5 years. Is it time to give them the boot?,https://finnhub.io/api/news?id=54542035994c9839321ff638ca9b35e8587e7bececf7a374096e9a80ffeec368
company,1768838820,"The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever",138178998,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,All three of these healthcare giants are leaders in their niches.,https://finnhub.io/api/news?id=e9939cfef0c4f38db1d0b06d2ca2ed24229091e544d012753c94937eb114cc79
company,1768837081,Transformative arrival of oral weight loss medicines in the US,138177942,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"While GlobalData does not expect oral Wegovy to substantially displace sales of injectable versions in 2026, some sales cannibalisation in the medium-term outlook is inevitable.",https://finnhub.io/api/news?id=d014e44bbb884726c8b63d1eb0c2d2246331afe3440c307eecbe37c26e190256
company,1768836249,Compounder sues Lilly and Novo for suppressing GLP-1RA competition,138177943,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.,https://finnhub.io/api/news?id=45be34343983be188be84e337c04ad7ca0993c5b306e87d7c8f8e6e9803c3b9b
company,1768835425,Podcast: JPM26’s dealmaking falls short of expectations,138177901,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming patent cliff and AI's growth in medtech.",https://finnhub.io/api/news?id=79ac97520c3274b9c75d4113b3e9dca11d4885c2ca6fe43e18bef3f770d0db2d
company,1768834740,Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already?,138178524,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,NVO shares jump 9.1% as early U.S. prescriptions for oral Wegovy show strong first-week demand after its early January launch.,https://finnhub.io/api/news?id=cb05e9b64c2674e2022ec89010d83e41c893466d5f60a9cff2c6bdaf602e0589
company,1768830346,Huge Insider Buying Now at This Insurance Giant and 2 Biotechs,138177945,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Alumis, Aktis Oncology, and W.R. Berkley saw the most prominent insider buying of the past week. There were a handful of other notable purchases as well.",https://finnhub.io/api/news?id=6141ffe3739b398eb464d103e6cbbba206beb156e03b900fd0a3393cfe67771d
company,1768827003,Eli Lilly’s Taltz and Zepbound Combo Delivers Superior Results in Landmark Psoriatic Arthritis Trial,138176991,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Eli Lilly and Company (NYSE:LLY) is one of the best future stocks to buy for the long term. On January 8, Eli Lilly announced positive topline results from the pioneering TOGETHER-PsA Phase 3b trial. This study is the first controlled pharmacologic trial to evaluate the combined use of an incretin therapy, Zepbound (tirzepatide), alongside a […]",https://finnhub.io/api/news?id=b76af655b8d95efcb25dd247fb0d79307b565eb12f34f6db342215e6b76d97b6
company,1768826280,Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan,138177946,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.,https://finnhub.io/api/news?id=503f4b6fbb9bb2db559370a3732a67ffc25763a4cff27963a2a84b662fa84d15
company,1768815000,Prediction: 2026 Will Be the Year of Eli Lilly,138175732,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,A catalyst lies just ahead.,https://finnhub.io/api/news?id=7798a36634e162a1340675188feadd8cc0dde9be2c857bf04dde075c1d69ce5b
company,1768814355,Where is NVIDIA Corporation (NVDA) Headed According to the Street?,138175719,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"NVIDIA Corporation (NASDAQ:NVDA) is one of the best strong buy growth stocks to buy according to hedge funds. NVIDIA Corporation (NASDAQ:NVDA) received a rating update from Jefferies on January 16, with the firm lifting the price target on the stock to $275 from $250 and maintaining a Buy rating on the shares. The firm told […]",https://finnhub.io/api/news?id=73fcde780a050f087cb6e08e8f4ac2f558f461c218de6e3f4a7ef3e113615430
company,1768785039,What Eli Lilly (LLY)'s NVIDIA AI Lab And Obesity Data Reveal About Its Obesity Leadership Narrative,138173427,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"In recent weeks, Eli Lilly has deepened its push into AI-driven drug discovery and obesity care, including a planned US$1.00 billion co-innovation lab with NVIDIA, new AI collaborations such as Chai Discovery and TuneLab integrations, and positive Phase 3b data combining Taltz with Zepbound in psoriatic arthritis and obesity. At the same time, Strive Compounding Pharmacy’s federal antitrust lawsuit against Eli Lilly and Novo Nordisk over compounded GLP-1 access underscores growing legal and...",https://finnhub.io/api/news?id=1d40f2717d59d59da33f6602aa437713e604dd40bdceabf2cb0941e0b7dcd1ad
